Qianyuan Pharmaceutical
SZSE · 300254
Market Cap$2.5B
Revenue$862.9M
Employees1162
Listed OnSZSE
Ticker300254
CEO / ExecMr. Qun Zhao
HeadquartersDatong
MarketMainland China
Websitewww.cy-pharm.com
Overview
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, commerce, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Ebastine tablets,
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.